Cataract  >>  mapracorat (BOL-303242-X)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mapracorat (BOL-303242-X) / Bayer
NCT00905450: Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery

Completed
2
415
US
BOL-303242-X, Mapracorat, Vehicle for BOL-303242-X
Bausch & Lomb Incorporated
Cataract, Inflammation
03/10
05/10

Download Options